granted patent: Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions

TitleCompositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions
Granted PatentUS 20080091233
Granted Date2008-04-17
Priority Date2006-04-25 US 11/745601P
2007-04-25 US 11/796132
Inventors
Issue Date2008
Citation
US Patent US 20080091233. Washington, DC: US Patent and Trademark Office (USPTO), 2008 How to Cite?
AbstractCompositions which self-assemble under physiological conditions are formulated for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may also include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer. The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract. The formulation may be applied to any site of bleeding, in a bandage, gauze, sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the initial treatment such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination with an oil and forms a laminate. In another embodiment, the formulation is provided as a coating on a device, for example a stent or a catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent transplantation or reattachment, and as a bulking, stabilizing or hydrating agent.
Persistent Identifierhttp://hdl.handle.net/10722/210492
References

 

DC FieldValueLanguage
dc.date.accessioned2015-06-17T07:02:45Z-
dc.date.available2015-06-17T07:02:45Z-
dc.date.issued2008-
dc.identifier.citationUS Patent US 20080091233. Washington, DC: US Patent and Trademark Office (USPTO), 2008-
dc.identifier.urihttp://hdl.handle.net/10722/210492-
dc.description.abstractCompositions which self-assemble under physiological conditions are formulated for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may also include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer. The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract. The formulation may be applied to any site of bleeding, in a bandage, gauze, sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the initial treatment such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination with an oil and forms a laminate. In another embodiment, the formulation is provided as a coating on a device, for example a stent or a catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent transplantation or reattachment, and as a bulking, stabilizing or hydrating agent.-
dc.relation.isreferencedbyUS 2011196326 (A1) 2011-08-11 -
dc.relation.isreferencedby U S8524796 (B2) 2013-09-03-
dc.relation.isreferencedbyUS 2009036851 (A1) 2009-02-05 -
dc.relation.isreferencedby U S7906478 (B2) 2011-03-15-
dc.relation.isreferencedbyDE 102013211316 (A1) 2014-12-18-
dc.relation.isreferencedbyWO 2013025610 (A1) 2013-02-21-
dc.relation.isreferencedbyUS 2012016223 (A1) 2012-01-19 -
dc.relation.isreferencedby U S8515525 (B2) 2013-08-20-
dc.relation.isreferencedby U S8153582 (B2) 2012-04-10-
dc.relation.isreferencedbyWO 2010148400 (A1) 2010-12-23-
dc.relation.isreferencedbyUS 2010041292 (A1) 2010-02-18 -
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documents-
dc.titleCompositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions-
dc.typePatent-
dc.identifier.authoritySO KWOK-FAI=rp00329-
dc.identifier.authorityELLIS-BEHNKE RUTLEDGE=rp00252-
dc.identifier.authorityLIANG YU-XIANG=rp00510-
dc.identifier.authorityTAY DAVID=rp00336-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorELLIS-BEHNKE RUTLEDGE-
dc.contributor.inventorLIANG YU-XIANG-
dc.contributor.inventorSCHNEIDER GERALD E-
dc.contributor.inventorSO KWOK-FAI-
dc.contributor.inventorTAY DAVID-
patents.identifier.applicationUS 11/796132-
patents.identifier.grantedUS 20080091233-
patents.description.assigneeMASSACHUSETTS INST TECHNOLOGY [US] -
patents.description.countryUnited States of America -
patents.date.granted2008-04-17-
dc.relation.referencesUS 2010021344 (A1) 2010-01-28 -
dc.relation.references U S8021570 (B2) 2011-09-20-
dc.relation.referencesUS 2005107289 (A1) 2005-05-19-
patents.identifier.hkutechidAnat-2006-00186A-1-
patents.date.application2007-04-25-
patents.date.priority2006-04-25 US 11/745601P-
patents.date.priority2007-04-25 US 11/796132-
patents.description.ccus-
patents.relation.familyWO 2007142757 (A2) 2007-12-13 -
patents.relation.familyAU 2007257425 (A1) 2007-12-13-
patents.relation.familyCA 2650230 (A1) 2007-12-13-
patents.relation.familyCA 2722465 (A1) 2008-11-06-
patents.relation.familyCN 101472620 (A) 2009-07-01-
patents.relation.familyEP 2012842 (A2) 2009-01-14-
patents.relation.familyEP 2150268 (A1) 2010-02-10-
patents.relation.familyEP 2581097 (A1) 2013-04-17-
patents.relation.familyJP 2009535338 (A) 2009-10-01-
patents.relation.familyJP 2010526779 (A) 2010-08-05-
patents.relation.familyKR 20090015935 (A) 2009-02-12-
patents.relation.familyKR 20110091019 (A) 2011-08-10-
patents.relation.familyUS 2008032934 (A1) 2008-02-07-
patents.relation.familyWO 2008134544 (A1) 2008-11-06-
patents.description.kindA1-
patents.typePatent_granted-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats